Corporate News     09-Dec-22
Alembic Pharmaceuticals receives USFDA approval for Desonide Cream
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Desonide Cream, 0.05%. The ANDA was filed by Aleor Dermaceuticals Limited (Aleor) which was amalgamated with Alembic. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05%, of Padagis US LLC. Desonide Cream, 0.05% is a Low potency corticosteroid indicated for the relief of inflammatory and Pruritic manifestations of corticosteroid-responsive dermatoses. Refer to our label for full indication.

Desonide Cream, 0.05%, has an estimated market size of US$12 million for twelve months ending Sep 2022 according to IQVIA.

Alembic has received a cumulative total of 178 ANDA approvals (155 final approvals and 23 tentative approvals) from USFDA.

Previous News
  Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
 ( Hot Pursuit - 08-Aug-24   15:48 )
  Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 13-Aug-24   12:15 )
  Alembic Pharma hits record high on USFDA nod for anti psychotic drug
 ( Hot Pursuit - 24-Jul-24   14:43 )
  Alembic Pharmaceuticals consolidated net profit rises 48.01% in the December 2023 quarter
 ( Results - Announcements 05-Feb-24   14:52 )
  Alembic Pharmaceuticals receives USFDA final approval for Albendazole Tablets
 ( Corporate News - 05-Sep-24   13:21 )
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Alembic Pharma gets US FDA nod for anticoagulant Dabigatran
 ( Hot Pursuit - 13-Aug-24   13:46 )
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 02-Jan-24   14:30 )
  CRISIL reaffirms ratings of Alembic Pharmaceuticals with 'stable' outlook
 ( Hot Pursuit - 08-Mar-24   11:22 )
Other Stories
  ITD Cementation India wins order of Rs 1,937 cr
  03-Oct-24   10:35
  NIIT Learning Systems allots 1,666 equity shares under ESOP
  03-Oct-24   10:30
  Ashoka Metcast to discuss results
  03-Oct-24   10:29
  Emerald Finance to declare Quarterly Result
  03-Oct-24   10:29
  Rhetan TMT schedules board meeting
  03-Oct-24   10:29
  Shrenik to table results
  03-Oct-24   10:29
  Universal Arts to declare Quarterly Result
  03-Oct-24   10:28
  Three M Paper Boards to conduct board meeting
  03-Oct-24   10:28
  Arkade Developers to declare Quarterly Result
  03-Oct-24   10:28
  Worth Investment & Trading Company announces board meeting date
  03-Oct-24   10:28
Back Top